Canada markets closed

Provectus Biopharmaceuticals, Inc. (PXY.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.04500.0000 (0.00%)
At close: 02:55PM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
76.576
21.605
682.984
97.231
-
Total Cash
76.576
21.605
682.984
97.231
-
Net Receivables
0.476
0.394
5.107
3.93
-
Other Current Assets
337.522
467.081
329.908
322.518
-
Total Current Assets
1,365
1,899
3,442
423.679
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
195.04
240.137
162.577
243.835
-
Accumulated Depreciation
-110.994
-102.073
-91.178
-78.313
-
Net property, plant and equipment
84.046
138.064
71.399
165.522
-
Intangible Assets
-
-
-
-
228.107
Total non-current assets
84.046
138.064
71.399
165.522
-
Total Assets
1,449
2,037
3,513
589.201
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
2,953
2,067
1,698
23,628
-
Accounts Payable
1,676
2,094
1,287
956.86
-
Accrued liabilities
963.29
461.182
2,019
6,042
-
Deferred revenues
953.248
1,511
2,500
0
-
Other Current Liabilities
-
-
150
-
0.001
Total Current Liabilities
9,017
8,192
7,701
30,712
-
Non-current liabilities
Long Term Debt
-
-
-
39.061
19,667
Total non-current liabilities
25.299
73.376
0
83.844
-
Total Liabilities
9,042
8,266
7,701
30,796
-
Stockholders' Equity
Common Stock
442.256
441.617
441.039
398.808
-
Retained Earnings
-252,690
-249,589
-246,034
-240,494
-
Accumulated other comprehensive income
-60.165
-35.679
-34.467
-34.097
-
Total stockholders' equity
-7,593
-6,229
-4,187
-30,206
-
Total liabilities and stockholders' equity
1,449
2,037
3,513
589.201
-